
MOLN P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.99
Average-1.98
Median-1.99
Minimum-2.11
Maximum-1.85
-1.99
Past Month+0.13 (6.13%)
The P/E ratio for MOLN is -1.99 as of Jun 13, 2025. This represents a decrease of -23.75% compared to its 12-month average P/E ratio of -2.61. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Molecular Partners AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Molecular Partners AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Molecular Partners AG to industry peers.
Molecular Partners AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Molecular Partners AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Molecular Partners AG to industry peers.
MOLN P/E Ratio Insights
See Molecular Partners AG’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in MOLN
Order type
Buy in
Order amount
Est. shares
0 shares
MOLN P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.79 | -1.97 |
May 1, 2025 | $3.7475 | -2.07 |
Apr 1, 2025 | $3.84 | -2.12 |
Mar 3, 2025 | $5.03 | -2.34 |
Feb 3, 2025 | $5.05 | -2.35 |
Jan 2, 2025 | $4.87 | -2.27 |
MOLN End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.99 | -9.95% |
2024 | -2.21 | +1.84% |
2023 | -2.17 | -231.52% |
2022 | 1.65 | -119.46% |
2021 | -8.48 | — |
FAQs About Molecular Partners AG (MOLN) P/E ratio
The latest P/E ratio of MOLN is -1.99, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Molecular Partners AG’s last 12-month average P/E ratio is -2.61, compared to its current P/E ratio of -1.99. This reflects a decrease of -23.75%.
Molecular Partners AG’s current P/E ratio of -1.99 is lower than its last 12-month average P/E of -2.61. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Molecular Partners AG’s average P/E ratio over the last 3 years is -1.57. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Molecular Partners AG’s average P/E ratio over the last 5 years is -2.14. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.